Abstract
The interaction of ligands with G protein-coupled receptors (GPCRs) has been traditionally studied using radiolabelled variants of receptor ligands. More recently, increased knowledge about the way in which GPCRs exist in a highly organised membrane environment has led to an interest in investigating receptor–ligand interactions in single cells. In addition, substantial improvements in imaging technology and an increase in the expense of radioactive waste disposal have resulted in an expansion in the use of fluorescent technologies. One major requirement for these methods is a suitable fluorescent ligand for the receptor of interest. The design of fluorescent ligands for GPCRs is complex, and has to take into account their pharmacological, photophysical, and also physicochemical properties. Here, we describe some basic considerations in the design of fluorescent GPCR ligands, including choice of pharmacological template, linker, and fluorophore. In addition, we describe basic protocols for determining the photophysical properties of the ligand and determining the cellular localisation of their interaction with the target receptors. Finally, we provide a basic protocol for using fluorescent GPCR ligands to quantify the number and diffusion of receptor–ligand complexes in small areas of the cell membrane.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Middleton, R.J., and Kellam B. (2005) Fluorophore-tagged GPCR ligands. Curr. Op. Chem. Biol. 9, 517–525.
Daly, C.J. and McGrath, J.C. (2003) Fluorescent ligands, antibodies, and proteins for the study of receptors. Pharmacol. Ther. 100, 101–118.
Leopoldo, M., Lacivita, E., Berardi, F., and Perrone, R. (2009) Developments in fluorescent probes for receptor research. Drug. Discov. Today 14, 706–712.
Ostrom, R.S, and Insel, P.A. (2004) The evolving role of lipid rafts and caveolae in G protein-coupled receptor signalling: implication for molecular pharmacology. Br. J. Pharmacol. 143, 235–245.
Insel, P.A., Head, B.P., Ostrom, R.S., Patel, H.H., Swaney, J.S., Tang, C.M., Roth, D.M. (2005) Caveolae and lipid rafts: G-protein-coupled receptor signalling microdomains in cardiac myocytes. Ann. N.Y. Acad. Sci. 1047, 166–172.
Hern, J.A., Baig, A.H., Mashanov, G.I., Birdsall, B., Corrie, J.E., Lazareno, S., Molloy, J.E., and Birdsall, N.J. (2010) Formation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single molecules. Proc. Natl. Acad. Sci. USA 107, 2693–2698.
Miquel, M.R., Segura, V., Ali, Z., D’Ocon, M.P., McGrath, J.C., and Daly, C.J. (2005) 3-D image analysis of fluorescent drug binding. Mol. Imaging 4, 40–52.
Briddon, S.J., Cordeaux, Y., Middleton, R.J., Weinstein, J, George, M.W., Kellam, B., and Hill, S.J. (2004) Quantitative analysis of the formation and diffusion of A(1)-adenosine receptor-antagonist complexes in single living cells Proc. Natl. Acad. Sci. USA 101, 4673–4678.
Daly, C.J., Ross, R., Whyte, J., Henstridge, C., Irving, A., and McGrath, J. (2010) Fluorescent ligand binding reveals heterogeneous distribution of adrenoceptors and ‘cannabinoid-like’ receptors in small arteries. Br. J. Pharmacol. In Press, DOI: 10.1111/j.1476-5381.2009.00608.x
Jones, J.W., Greene, T.A., Grygon, C.A., Doranz, B.J., and Brown, M.P. (2008) Cell-free assay of G-protein-coupled receptors using fluorescence polarization. J. Biomol. Screen 13, 424–429.
Harikumar, K.G., Pinon, D.L. and Miller, L.J. (2006) Fluorescence characteristics of hydrophobic partial agonist probes of the cholecystokinin receptor. Biosci. Rep. 26, 89–100.
Harikumar, K.G., Hosohata, K., Pinon, D.I., and Miller, L.J. (2006) Use of probes with fluorescent indicator distributed throughout the pharmacophore to examine the peptide agonist-binding environment of the family B G protein-coupled secretin receptor. J. Biol. Chem. 281, 2543–2550.
Ilien, B., Franchet, C., Bernard, P., Morisset, S., Well, C.O., Bourguignon, J.J., Hibert, M., and Galzi, J.L. (2003) Fluorescence resonance energy transfer to probe human M1 muscarinic receptor structure and drug binding properties. J. Neurochem. 85, 768–778.
Tahtaoui, C., Guillier, F., Klotz, P., Galzi, J.L., Hibert, M. and Ilien, B (2005) On the use of nonfluorescent dye labelled ligands in FRET-based receptor binding studies. J. Med. Chem. 48, 7847–7859.
Middleton, R.J., Briddon, S.J., Cordeaux, Y., Yates, A.S., Dale, C.L., George, M.W., Baker, J.G., Hill, S.J., and Kellam, B. (2007) New fluorescent adenosine A1-receptor agonists which allow quantification of ligand-receptor interactions in microdomains of single living cells. J. Med. Chem. 50, 782–793.
Briddon, S.J. and Hill, S.J. (2007) Pharmacology under the microscope: the use of fluorescence correlation spectroscopy to determine the properties of ligand receptor complexes. Trends Pharmacol. Sci. 28, 637–645.
Cordeaux Y, Briddon SJ, Alexander SPH, Kellam B & Hill SJ (2008) Agonist-occupied A3 adenosine receptors exist within heterogeneous complexes in membrane microdomains of individual living cells. FASEB J. 22, 850–860.
Hegener O, Prenner L, Runkel F, Baader SL, Kappler J & Haberlein H (2004) Dynamics of beta2-adrenergic receptor-ligand complexes on living cells. Biochemistry 43, 6190–6199.
Ziemek, R., Brennauer, A., Schneider, E., Cabrele, C., Beck-Sickinger, A.G., Bernhardt, G., and Buschauer, A. (2006) Fluorescence- and luminescence -based methods for the determination of affinity and activity of neuropeptide Y2 receptor. Eur. J. Pharmacol. 551, 10–18.
Schwille P (2001) Fluorescence correlation spectroscopy and its potential for intracellular applications Cell Biochem. Biophys. 34, 383–408.
Kim S, Heinze K & Schwille P (2007) Fluorescence correlation spectroscopy in living cells. Nat. Methods 4, 963–973.
Baker, J.G., Middleton, R.J., Adams, L., Briddon, S.J., Kellam, B, and Hill, S.J. (2010) Pharmacological characteristics of different fluorescent ligands at the human adenosine-A1 receptor. Br. J. Pharmacol 159, 772–786.
Wohland T, Friedrich K, Hovius R & Vogel H (1999) Study of ligand-receptor interactions by fluorescence correlation spectroscopy with different fluorophores: evidence that the homopentameric 5-hydroxytryptamine type 3As receptor binds only one ligand. Biochemistry 38, 8671–8681.
Cornelius, P., Lee, E., Lin, W., Wang, R., Werner, W., Brown, J.A., Stuhmeier, F., Boyd, J.G., and McClure, K. (2009) Design, synthesis and pharmacology of fluorescently labeled analogs of serotonin: application to screening of the 5-HT2C receptor. J. Biomol. Screen. 14, 360–370.
Briddon, S.J., Hern, J.A., and Hill, S.J. (2009) Use of fluorescence correlation spectroscopy to study GPCRs. In G-protein coupled receptors – Essential Methods (Poyner, D. and Wheatley, M., ed.), Wiley-Blackwell, 169–191.
Pramanik A & Rigler R (2001) FCS-analysis of ligand-receptor interactions in living cells. In Fluorescence Correlation Spectroscopy: Theory and Applications, (Elson, E. & Rigler, R., ed.) Springer, Heidelberg. 101–129.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Briddon, S.J., Kellam, B., Hill, S.J. (2011). Design and Use of Fluorescent Ligands to Study Ligand–Receptor Interactions in Single Living Cells. In: Willars, G., Challiss, R. (eds) Receptor Signal Transduction Protocols. Methods in Molecular Biology, vol 746. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-126-0_11
Download citation
DOI: https://doi.org/10.1007/978-1-61779-126-0_11
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-125-3
Online ISBN: 978-1-61779-126-0
eBook Packages: Springer Protocols